1921
Volume 95, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Histoplasmosis is common among persons living with human immunodeficiency virus/acquired immune deficiency syndrome (PLWHA) in Latin America, but its diagnosis is difficult and often nonspecific. We conducted prospective screening for histoplasmosis among PLWHA with signs or symptoms suggesting progressive disseminated histoplasmosis (PDH) and hospitalized in Hospital La María in Medellín, Colombia. The study's aim was to obtain a clinical and laboratory profile of PLWHA with PDH. During 3 years (May 2008 to August 2011), we identified 89 PLWHA hospitalized with symptoms suggestive of PDH, of whom 45 (51%) had histoplasmosis. We observed tuberculosis (TB) coinfection in a large proportion of patients with PDH (35%), so all analyses were performed adjusting for this coinfection and, alternatively, excluding histoplasmosis patients with TB. Results showed that the patients with PDH were more likely to have Karnofsky score ≤ 30 (prevalence ratio [PR] = 1.98, 95% confidence interval [CI] = 0.97–4.06), liver compromised with hepatomegaly and/or splenomegaly (PR = 1.77, CI = 1.03–3.06) and elevation in serum of alanine aminotransferase and aspartate aminotransferase to values > 40 mU/mL (PR = 2.06, CI = 1.09–3.88 and PR = 1.53, CI = 0.99–2.35, respectively). Using multiple correspondence analyses, we identified in patients with PDH a profile characterized by the presence of constitutional symptoms, namely weight loss and Karnofsky classification ≤ 30, gastrointestinal manifestations with alteration of liver enzymes and hepatosplenomegaly and/or splenomegaly, skin lesions, and hematological alterations. Study of the profiles is no substitute for laboratory diagnostics, but identifying clinical and laboratory indicators of PLWHA with PDH should allow development of strategies for reducing the time to diagnosis and thus mortality caused by .

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0837
2016-10-05
2017-11-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/95/4/918.html?itemId=/content/journals/10.4269/ajtmh.15-0837&mimeType=html&fmt=ahah

References

  1. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M, , 2011. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 49: 785798.
  2. Knox KS, Hage CA, , 2010. Histoplasmosis. Proc Am Thorac Soc 7: 169172.[Crossref]
  3. Deepe GS, Bennett JE, Dolin R, Blaser MJ, , 2015. Histoplasma capsulatum. , eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier, 29492962.
  4. Pfaller MA, Diekema DJ, , 2010. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36: 153.[Crossref]
  5. Scheel CM, Gómez BL, , 2014. Diagnostic methods for histoplasmosis: focus on endemic countries with variable infrastructure levels. Curr Trop Med Rep 1: 129137.
  6. Gaviria A, Muñoz NJ, Ruiz F, Burgos G, Osorio EJ, Ospina ML, , 2014. Informe GARPR–2014: Seguimiento de la Declaración de compromiso sobre el VIH/sida. Available at: http://www.unaids.org/sites/default/files/country/documents//file%2C94471%2Ces.pdf. Accessed April 11, 2014.
  7. Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, Linares M, Valencia Y, Restrepo A, Colombian Histoplasmosis Study Group, , 2011. Histoplasmosis: results of the Colombian National Survey, 1992–2008. Biomédica 31: 344356.[Crossref]
  8. Caceres DH, Zuluaga A, Arango-Bustamante K, de Bedout C, Tobón ÁM, Restrepo Á, Gómez BL, Cano LE, González Á, , 2015. Implementation of a training course increased the diagnosis of histoplasmosis in Colombia. Am J Trop Med Hyg 93: 662667.[Crossref]
  9. Huber F, Nacher M, Aznar C, Pierre-Demar M, El Guedj M, Vaz T, Vantilcke V, Mahamat A, Magnien C, Chauvet E, Carme B, Couppié P, , 2008. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS 22: 10471053.[Crossref]
  10. Mora DJ, dos Santos CT, Silva-Vergara ML, , 2008. Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil. Mycoses 51: 136140.[Crossref]
  11. Karimi K, Wheat LJ, Connolly P, Cloud G, Hajjeh R, Wheat E, Alves K, Lacaz C d C da S, Keath E, , 2002. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 186: 16551660.[Crossref]
  12. Pietrobon D, Negro-Marquinez L, Kilstein J, Galindez J, Greca A, Battagliotti C, , 2004. Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment. Enferm Infecc Microbiol Clin 22: 156159.[Crossref]
  13. Corti ME, Negroni R, Esquivel P, Villafañe MF, , 2004. Histoplasmosis diseminada en pacientes con SIDA: análisis epidemiológico, clínico, microbiológico e inmunológico de 26 pacientes. Enf Emerg 6: 815.
  14. Couppié P, Sobesky M, Aznar C, Bichat S, Clyti E, Bissuel F, El Guedj M, Alvarez F, Demar M, Louvel D, Pradinaud R, Carme B, , 2004. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 38: 134138.[Crossref]
  15. Scheel CM, Samayoa B, Herrera A, Lindsley MD, Benjamin L, Reed Y, Hart J, Lima S, Rivera BE, Raxcaco G, Chiller T, Arathoon E, Gómez BL, , 2009. Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients. Clin Vaccine Immunol 16: 852858.[Crossref]
  16. Chang MR, Taira CL, Paniago AM, Taira DL, Cunha RV, Wanke B, , 2007. Study of 30 cases of histoplasmosis observed in the Mato Grosso do Sul State, Brazil. Rev Inst Med Trop Sao Paulo 49: 3739.[Crossref]
  17. de Francesco Daher E, de Sousa Barros FA, da Silva Júnior GB, Takeda CF, Mota RM, Ferreira MT, Martins JC, Oliveira SA, Gutiérrez-Adrianzén OA, , 2006. Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis. Am J Trop Med Hyg 74: 600603.
  18. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L, , 2005. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 40: 11991202.[Crossref]
  19. Velásquez Uribe G, Rueda ZV, Vélez LA, Aguirre DC, Gómez-Arias RD, , 2010. Histoplasmosis in AIDS patients: a cohort study in Medellín, Colombia. Infectio 14: s99s106.[Crossref]
  20. Cáceres DH, Gómez BL, Restrepo Á, Tobón ÁM, , 2012. Histoplasmosis y sida: factores de riesgo clínico y de laboratorio asociados al pronóstico de la enfermedad. Infectio Supl 3: 4450.[Crossref]
  21. Kauffman CA, , 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115132.[Crossref]
  22. Thompson GR, Gómez BL, Jorgensen JH, Pfaller MA, Carroll KC, Landry ML, Funke G, Richter SS, Warnock DW, , 2015. Histoplasma, blastomyces, coccidioides, and other dimorphic fungi causing systemic mycoses. , eds. Manual of Clinical Microbiology, 11th edition, Chapter 122. Washington, DC: ASM Press, 21092127.
  23. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, , 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 18131821.[Crossref]
  24. Briand S, Beresniak A, Nguyen T, Yonli T, Duru G, Kambire C, Perea W, Yellow Fever Risk Assessment Group (YF-RAG), , 2009. Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach. PLoS Negl Trop Dis 14: e483.[Crossref]
  25. Moreno ES, Barata R de C, , 2012. Methodology for definition of yellow fever priority areas, based on environmental variables and multiple correspondence analyses. PLoS Negl Trop Dis 6: e1658.[Crossref]
  26. Nacher M, Adenis A, Mc Donald S, Do Socorro Mendonca Gomes M, Singh S, Lopes Lima I, Malcher Leite R, Hermelijn S, Wongsokarijo M, Van Eer M, Marques Da Silva S, Mesquita Da Costa M, Silva M, Calvacante M, do Menino Jesus Silva Leitao T, Gómez BL, Restrepo A, Tobon A, Canteros CE, Aznar C, Blanchet D, Vantilcke V, Vautrin C, Boukhari R, Chiller T, Scheel C, Ahlquist A, Roy M, Lortholary O, Carme B, Couppié P, Vreden S, , 2013. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 7: e2319.[Crossref]
  27. Adenis AA, Aznar C, Couppié P, , 2014. Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps. Curr Trop Med Rep 28: 119128.
  28. Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Many WJ, Jr, 2008. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis 62: 151156.[Crossref]
  29. Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R, , 2000. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 30: 877881.[Crossref]
  30. Daher EF, Silva GB, Jr Barros FA, Takeda CF, Mota RM, Ferreira MT, Oliveira SA, Martins JC, Araújo SM, Gutiérrez-Adrianzén OA, , 2007. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Int Health 12: 11081115.[Crossref]
  31. Casotti JA, Motta TQ, Ferreira CU, Jr Cerutti C, Jr, 2006. Disseminated histoplasmosis in HIV positive patients in Espirito Santo state, Brazil: a clinical-laboratory study of 12 cases (1999–2001). Braz J Infect Dis 10: 327330.[Crossref]
  32. Antinori S, Magni C, Nebuloni M, Parravicini C, Corbellino M, Sollima S, Galimberti L, Ridolfo AL, Wheat LJ, , 2006. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 85: 2236.[Crossref]
  33. Agudelo CA, Restrepo CA, Molina DA, Tobón AM, Kauffman CA, Murillo C, Restrepo A, , 2012. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg 87: 10941098.[Crossref]
  34. Adenis A, Nacher M, Hanf M, Basurko C, Dufour J, Huber F, Aznar C, Carme B, Couppié P, , 2014. Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. Am J Trop Med Hyg 90: 216223.[Crossref]
  35. Nacher M, Adenis A, Sambourg E, Huber F, Abboud P, Epelboin L, Mosnier E, Vantilcke V, Dufour J, Djossou F, Demar M, Couppié P, , 2014. Histoplasmosis or tuberculosis in HIV-infected patients in the amazon: what should be treated first? PLoS Negl Trop Dis 8: e3290.[Crossref]
  36. Sterling TR, Chaisson RE, Mandel GL, Bennett JE, Dolin R, , 2010. General clinical manifestations of human immunodeficiency virus infection (including the acute retroviral syndrome and oral cutaneous, renal, ocular, metabolic and cardiac diseases). , eds. Principles and Practice of Infectious Diseases. 17051725.
  37. Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, Phelan MA, Cloud G, Holloway M, Kauffman CA, Wheat LJ, National Institute of Allergy and Infectious Diseases Mycoses Study Group, , 2001. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 32: 12151220.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0837
Loading
/content/journals/10.4269/ajtmh.15-0837
Loading

Data & Media loading...

  • Received : 18 Nov 2015
  • Accepted : 12 May 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error